When was Replication Medical founded?

Replication Medical was founded in 2001 and raised its 1st funding round 8 years after it was founded.

Where is Replication Medical located?

Replication Medical is headquartered in Cranbury, United States.

Who is the current CEO of Replication Medical?

Ann Prewett of Replication Medical.

How many employees does Replication Medical have?

As of Jul 01, 2024, the latest employee count at Replication Medical is 11 - 50.

Is Replication Medical a funded company?

Replication Medical is a funded company, having raised a total of $1.71M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Dec 09, 2009.

When was the latest funding round of Replication Medical?

Replication Medical's latest funding was a $***** Seed round on Apr 25, 2011, with participation from 0 investor. Its primary sector is Orthopedics. In United States, the Orthopedics sector has seen $505M in funding in 2026 to date.

Where does Replication Medical rank among its competitors?

Replication Medical ranks 141st amongst 241 active competitors, of which 58 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Spineology, which secured $8.76M in Nov, 2025.

Who are the top competitors of Replication Medical?

Replication Medical's top competitors include Si-Bone, Paradigm Spine and ATEC Spine. Among them, Spineology secured the most recent funding round in November, 2025.

Replication Medical - 2026 Company Profile, Team, Funding & Competitors

Replication Medical is a seed company based in Cranbury (United States), founded in 2001 by David Anderson. It operates as a Biocompatible medical implants for back pain. Replication Medical has raised $1.71M in funding. The company has 241 active competitors, including 58 funded and 61 that have exited. Its top competitors include companies like Si-Bone, Paradigm Spine and ATEC Spine.

Company Details

Replication Medical is a medical device company which relies upon its proprietary hydrogel technology to produce biocompatible medical implants. The company is currently focused on developing solutions for back pain. It sells EnGuard, a hydrogel cover that protects spinal blood vessels following surgery. The biocompatible substance is permeable to water-soluble compounds and holds its shape effectively. The company also markets this product abroad, along with its GelGuard, GelFix, and GelStix implants.

Website: replicationmedical.com
Social

Key Metrics

Founded Year

2001

Location

Cranbury, United States

Stage

Seed

Total Funding

$1.71M in 3 rounds

Latest Funding Round

Seed, Apr 25, 2011, $*****

Investors

Cardinal Partners

Ranked

141^st among 241 active competitors

Employee Count

11 - 50 as on Jul 01, 2024

Similar Companies

Si-Bone & 335 more

View Replication Medical's full profile

Replication Medical has raised a total funding of $1.71M over 3 rounds. Its first funding round was on Dec 09, 2009. Replication Medical has 1 institutional investor.

Here is the list of recent funding rounds of Replication Medical:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 25, 2011	2518365	Seed	2751948	8353758	6307961	1407219
May 29, 2010	7335805	Seed	4025941	9709383	7881895	7080853
Dec 09, 2009	2757371	Seed	5552300	1122631	6450579	4125992

Access funding benchmarks and valuations. Sign up today!

View details of Replication Medical's funding rounds and investors

The founders of Replication Medical is David Anderson.

Here are the details of Replication Medical's key team members:

David Anderson: Former Founder & Director of Replication Medical.
Ann Prewett: CEO of Replication Medical.
Contact Info: 1 email address

View details of Replication Medical's Founder profiles and Board Members

Replication Medical's employee count trend

Replication Medical has 11 - 50 employees as of Jul 24. Here is Replication Medical's employee count trend over the years:

Employee count trend for Replication Medical

Uncover Replication Medical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Replication Medical include Si-Bone, Paradigm Spine and ATEC Spine. Here is the list of Top 10 competitors of Replication Medical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Si-Bone 2008, San Jose (United States), Public	Titanium implant fixation system	$103M	Skyline Ventures, Arboretum Ventures & 9 others	64/100
2nd	Paradigm Spine 2005, New York City (United States), Acquired	Manufacturer of stabilization devices for the healthcare industry	$142M	Athyrium Capital Management, HealthCor Partners ... & 6 others	64/100
3rd	ATEC Spine 1990, San Diego (United States), Public	Developer of treatment solutions for spine disorders	-	Deerfield, Armistice Capital & 11 others	62/100
4th	LimiFlex 2008, San Carlos (United States), Series C	Developer of spinal implants for treating spinal stenosis	$25.3M	Scientific Health Development, Doorga & 2 others	61/100
5th	Accelus 2016, Palm Beach Gardens (United States), Series D	Provider of spine surgery robot systems for healthcare industries	$20.8M	Concord Health Partners, Symbiotic Capital ... & 3 others	60/100
6th	Spineart 2005, Plan les Ouates (Switzerland), Series B	Developer of orthopedic implants and minimally invasive instruments	$139M	Ernst Göhner, Gimv & 2 others	59/100
7th	Spineology 1997, St. Paul (Canada), Late Stage	Developer of minimally invasive spinal surgery devices	$75.7M	SV Health Investors, Groundswell Ventures ... & 6 others	58/100
8th	Companion Spine 2020, New York City (United States), Series A	Developer of medical devices for spine treatment and therapies	$68.6M	Viscogliosi Brothers, IRDI Capital Investissement ... & 2 others	55/100
9th	Aurora Spine 2012, San Diego (United States), Public	Minimally invasive spine and SI joint solutions improving patient lives	-	-	54/100
10th	Wenzel Spine 2008, Austin (United States), Series A	Innovative spine technologies improving patient quality of life through simplified surgery	$5.8M	iNetworks, Wild Basin Investments & 2 others	53/100
141st	Replication Medical 2001, Cranbury (United States), Seed	Biocompatible medical implants for back pain	$1.71M	Cardinal Partners	26/100